全文获取类型
收费全文 | 1001篇 |
免费 | 49篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 23篇 |
妇产科学 | 36篇 |
基础医学 | 99篇 |
口腔科学 | 28篇 |
临床医学 | 101篇 |
内科学 | 198篇 |
皮肤病学 | 33篇 |
神经病学 | 18篇 |
特种医学 | 151篇 |
外科学 | 131篇 |
综合类 | 49篇 |
一般理论 | 4篇 |
预防医学 | 80篇 |
眼科学 | 14篇 |
药学 | 65篇 |
肿瘤学 | 24篇 |
出版年
2017年 | 5篇 |
2015年 | 11篇 |
2014年 | 4篇 |
2013年 | 15篇 |
2012年 | 4篇 |
2011年 | 6篇 |
2010年 | 14篇 |
2009年 | 21篇 |
2008年 | 7篇 |
2007年 | 10篇 |
2006年 | 4篇 |
2005年 | 6篇 |
2001年 | 9篇 |
1999年 | 14篇 |
1998年 | 32篇 |
1997年 | 48篇 |
1996年 | 49篇 |
1995年 | 25篇 |
1994年 | 33篇 |
1993年 | 28篇 |
1992年 | 15篇 |
1991年 | 9篇 |
1990年 | 25篇 |
1989年 | 27篇 |
1988年 | 23篇 |
1987年 | 26篇 |
1986年 | 16篇 |
1985年 | 28篇 |
1984年 | 19篇 |
1983年 | 27篇 |
1982年 | 27篇 |
1981年 | 25篇 |
1980年 | 18篇 |
1979年 | 14篇 |
1978年 | 13篇 |
1977年 | 18篇 |
1976年 | 12篇 |
1963年 | 6篇 |
1961年 | 5篇 |
1960年 | 3篇 |
1959年 | 30篇 |
1958年 | 53篇 |
1957年 | 41篇 |
1956年 | 49篇 |
1955年 | 45篇 |
1954年 | 33篇 |
1952年 | 4篇 |
1949年 | 30篇 |
1948年 | 37篇 |
1946年 | 4篇 |
排序方式: 共有1066条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Andrew BOFINGER Justin WESTHUYZEN David SALTISSI Colleen MORGAN Helen HEALY 《Nephrology (Carlton, Vic.)》1997,3(2):169-177
Summary: Uraemic dyslipidaemia is a major risk factor for cardiovascular disease in end-stage renal failure patients. In patients without renal failure, high levels and qualitative abnormalities of low-density lipoprotein (LDL) are known to be atherogenic. Recently, LDL subfraction analysis has associated premature coronary artery disease with a high prevalence of small, dense LDL particles characterizing the LDL subclass phenotype B. We therefore examined the lipid profiles, LDL subfraction distribution and phenotypes in our population of haemodialysis (HD; n = 30) and peritoneal dialysis patients (PD; n = 17), and compared them to 40 asymptomatic, non-uraemic volunteers. Dialysis patients had significantly higher triglyceride and VLDL cholesterol concentrations and lower HDL cholesterol and smaller LDL peak particle diameters. PD patients had significantly higher total cholesterol, glycated haemoglobin and fasting blood glucose levels with smaller LDL peak particle diameters (24.4 [0.1] vs 24.8 [0.1 nm] than HD. Both groups showed significant negative correlations between plasma triglyceride and LDL peak particle diameter, and positive correlations between HDL cholesterol and LDL peak particle diameter. All the PD patients expressed the B phenotype (LDL peak diameter ± 25.5 nm) compared to 73% of HD patients. This study demonstrates that HD and especially PD patients have atherogenic lipid profiles which are associated with a predominance of small dense LDL particles and the highly atherogenic LDL subclass phenotype B. 相似文献
5.
6.
Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results 总被引:3,自引:0,他引:3
Mattrey RF; Strich G; Shelton RE; Gosink BB; Leopold GR; Lee T; Forsythe J 《Radiology》1987,163(2):339-343
In animals, perfluorochemicals (PFCs) are effective ultrasound (US) contrast agents that produce hepatic, splenic, and tumor enhancement. The use of Fluosol-DA 20%, an emulsion of perfluorodecalin and perfluorotripropylamine, was studied in nine non-critically ill patients with cancer who had liver lesions. US studies without Fluosol were compared with studies obtained 24, 48, and 72 hours after Fluosol infusion. Vital signs and extensive laboratory analyses are performed before and after Fluosol infusion. Liver metastases from colonic, pancreatic, and gastric carcinoma exhibited rim or diffuse enhancement after a Fluosol dose of 1.6 g/kg or greater. Fluosol produced echogenic enhancement of the liver and spleen relative to kidney at a dose of 2.4 g/kg, allowing the detection of nonenhancing lesions. In addition, Fluosol at a dose of 1.6 g/kg or greater allowed detection of lesions not seen before contrast medium was administered in three of the seven patients studied. There was a mild increase in the level of serum glutamic oxaloacetic transaminase in two patients, one given 2.4 and the other 3.2 g/kg of Fluosol. Mild and transient allergic reactions without change in vital signs were experienced by two patients. 相似文献
7.
N. KUMAR GOGNA GRAEME MORGAN KATE DOWNS KERRY ATKINSON JAMES BIGGS 《Journal of Medical Imaging and Radiation Oncology》1992,36(4):317-320
The effect of dose rate to the lungs and development of interstitial pneumonitis (IP) was evaluated in 114 bone marrow transplant patients receiving fractionated total body irradiation (TBI) (1200 rads TD in 6 fractions twice daily over 3 days) as part of their pre-conditioning regimen. The tumour dose (TD) was calculated as the mean lung dose as previously described (1). A 6MV linear accelerator at a mid-line dose rate of 7.5 rads/minute was used between March 1981 and June 1985 and a Co-60 source at 5 rads/minute thereafter. This resulted in a range of dose rates to the lung of between 6.9 and 8.9 rads/minute and 2.9 and 6.5 rads/minute respectively. In the majority of patients the aetiology of IP was investigated by lung biopsy with histology and culture. There was no statistically significant difference in the incidence of IP over the two sets of dose rates. Our study suggests tat the incidence of IP using fractionated TBI is not influenced by dose rates below 8.9 rads per minute. 相似文献
8.
9.
10.